Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection
Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection
Not yet recruiting · NCT06701838 · Registry updated 2024-12-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection | ACTH-dependent Cushing syndrome, ACTH-producing pituitary gland adenoma, Cushing disease due to pituitary adenoma, Cushing syndrome, Neoplasms by Histologic Type, Neoplasms by Site, Pituitary Neoplasms, adenoma, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hyperpituitarism, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, neoplasm, nervous system disorder, pituitary gland adenoma, pituitary gland disorder, supratentorial cancer | Not yet recruiting | Not stated | 2024-12-03 | NCT06701838 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Imperial College London | 220 |
| University of Cambridge | 80 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||